Amanote Research
Register
Sign In
SUMOylation Plays a Role in Gemcitabine- And Bortezomib-Induced Cytotoxicity in Human Oropharyngeal Carcinoma KB Gemcitabine-Resistant Clone
Molecular Cancer Therapeutics
- United States
doi 10.1158/1535-7163.mct-05-0290
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
March 1, 2006
Authors
V. Chung
Publisher
American Association for Cancer Research (AACR)
Related search
Aspirin Inhibits Proliferation of Gemcitabine-Resistant Human Pancreatic Cancer Cells and Augments Gemcitabine-Induced Cytotoxicity
Acta Pharmacologica Sinica
Medicine
Pharmacology
Establishment and Characterization of the Gemcitabine‑resistant Human Pancreatic Cancer Cell Line SW1990/gemcitabine
Oncology Letters
Cancer Research
Oncology
Gemcitabine-Induced Extensive Skin Necrosis
Case Reports in Medicine
Medicine
Sumoylation of Kif18A Plays a Role in Regulating Mitotic Progression
BMC Cancer
Cancer Research
Oncology
Genetics
Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study
British Journal of Cancer
Cancer Research
Oncology
Brefeldin a Protects Ricin-Induced Cytotoxicity in Human Cancer KB Cell Line, but Not in Its Resistant Counterpart With Altered Golgi Structures.
Cell Structure and Function
Medicine
Cell Biology
Molecular Biology
Physiology
The Determinants of Sensitivity and Acquired Resistance to Gemcitabine Differ in Non-Small Cell Lung Cancer: A Role of ABCC5 in Gemcitabine Sensitivity
Molecular Cancer Therapeutics
Cancer Research
Oncology
Gemcitabine-Induced Chronic Systemic Capillary Leak Syndrome
BMJ Case Reports
Medicine
Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy
Oncotarget
Oncology
